0001140361-23-050019.txt : 20231027 0001140361-23-050019.hdr.sgml : 20231027 20231027195600 ACCESSION NUMBER: 0001140361-23-050019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231027 FILED AS OF DATE: 20231027 DATE AS OF CHANGE: 20231027 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GNI Hong Kong Ltd CENTRAL INDEX KEY: 0001958509 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51173 FILM NUMBER: 231356941 BUSINESS ADDRESS: STREET 1: 12/F ELITE CENTRE STREET 2: 22 HUNG TO ROAD CITY: KWUN TONG KL STATE: K3 ZIP: 0000 BUSINESS PHONE: 81-3-6214-3600 MAIL ADDRESS: STREET 1: 12/F ELITE CENTRE STREET 2: 22 HUNG TO ROAD CITY: KWUN TONG KL STATE: K3 ZIP: 0000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001124105 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562020050 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BLVD., SUITE 710 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-871-0761 MAIL ADDRESS: STREET 1: 611 GATEWAY BLVD., SUITE 710 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: TARGACEPT INC DATE OF NAME CHANGE: 20000919 4 1 form4.xml X0508 4 2023-10-27 true 0001124105 CATALYST BIOSCIENCES, INC. CBIO 0001958509 GNI Hong Kong Ltd 12/F ELITE CENTRE 22 HUNG TO ROAD KWUN TONG KL K3 HONG KONG true false Common Stock 2023-10-27 4 J 0 5371304 D 0 D Series X Convertible Preferred Stock 2023-10-27 4 J 0 10577 D Common Stock 105770000 0 D Represents an internal transfer by the Reporting Person, a wholly-owned indirect subsidiary of GNI Group Ltd., a company incorporated under the laws of Japan with limited liability ("GNI Japan"), to GNI Japan, pursuant to the Share Purchase Agreement, dated as of October 27, 2023, by and between the Reporting Person and GNI Japan, in exchange for consideration of $46,624,376. Shares of Series X Convertible Preferred Stock of the Issuer, par value $0.001 per share (the "Preferred Stock"), are convertible into shares of common stock of the Issuer at any time at the option of the holder thereof, based on the Conversion Ratio and subject to certain limitations, including the Beneficial Ownership Limitation (as such terms are defined in the Certificate of Designation for the Preferred Stock filed with the Securities and Exchange Commission as Exhibit 3.1 to the Issuer's Form 8-K filed on December 27, 2022). /s/ Branden Berns, as attorney-in-fact for GNI Hong Kong Ltd 2023-10-27